Validation of the oral health impact profile - 14 in patients with head and neck cancer.
Journal
Medicina oral, patologia oral y cirugia bucal
ISSN: 1698-6946
Titre abrégé: Med Oral Patol Oral Cir Bucal
Pays: Spain
ID NLM: 101231694
Informations de publication
Date de publication:
01 Nov 2020
01 Nov 2020
Historique:
received:
23
02
2020
accepted:
23
04
2020
pubmed:
11
5
2020
medline:
4
11
2020
entrez:
11
5
2020
Statut:
epublish
Résumé
The Oral Health Impact Profile-14 (OHIP-14) was designed to assess patients' perception of the impact of oral disorders on their quality of life (QoL). Although the OHIP-14 is now frequently used in patients with head and neck cancer, data related to its measurement properties in this population are scarce. The aim of the present study was to evaluate the reliability and validity of the OHIP-14 in a sample of Serbian patients with head and neck cancer. Data were available for 345 patients (257 [74.5%] males; aged 30-92 years), with head and neck cancer. All patients completed the OHIP-14 and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-H&N35. Factor analyses, internal consistency reliability (i.e., Cronbach's α coefficient), and construct validity were analyzed. The factor analyses confirmed that 14 OHIP items were measuring a single underlying factor. Cronbach's α coefficient was 0.98 and corrected item-total correlations ranged 0.77-0.93. Lower OHIP-14 scores (i.e., lower impacts on oral health) were more frequently present among patients who had only surgery as a therapeutic procedure compared to those who had surgery accompanied with radio- and chemotherapy (p < 0.01). Patients with a tumor stage 0-II also had lower OHIP-14 scores compared to those who had a tumor stage III-IV (p < 0.01). The OHIP-14 correlated significantly with the QLQ-C30 and QLQ-H&N35 scales. As a unidimensional instrument, the OHIP-14 provides oral QoL assessments with sound internal consistency reliability and construct validity among patients with head and neck cancer.
Sections du résumé
BACKGROUND
BACKGROUND
The Oral Health Impact Profile-14 (OHIP-14) was designed to assess patients' perception of the impact of oral disorders on their quality of life (QoL). Although the OHIP-14 is now frequently used in patients with head and neck cancer, data related to its measurement properties in this population are scarce. The aim of the present study was to evaluate the reliability and validity of the OHIP-14 in a sample of Serbian patients with head and neck cancer.
MATERIAL AND METHODS
METHODS
Data were available for 345 patients (257 [74.5%] males; aged 30-92 years), with head and neck cancer. All patients completed the OHIP-14 and the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-H&N35. Factor analyses, internal consistency reliability (i.e., Cronbach's α coefficient), and construct validity were analyzed.
RESULTS
RESULTS
The factor analyses confirmed that 14 OHIP items were measuring a single underlying factor. Cronbach's α coefficient was 0.98 and corrected item-total correlations ranged 0.77-0.93. Lower OHIP-14 scores (i.e., lower impacts on oral health) were more frequently present among patients who had only surgery as a therapeutic procedure compared to those who had surgery accompanied with radio- and chemotherapy (p < 0.01). Patients with a tumor stage 0-II also had lower OHIP-14 scores compared to those who had a tumor stage III-IV (p < 0.01). The OHIP-14 correlated significantly with the QLQ-C30 and QLQ-H&N35 scales.
CONCLUSIONS
CONCLUSIONS
As a unidimensional instrument, the OHIP-14 provides oral QoL assessments with sound internal consistency reliability and construct validity among patients with head and neck cancer.
Identifiants
pubmed: 32388514
pii: 23765
doi: 10.4317/medoral.23765
pmc: PMC7648921
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e739-e744Références
Med Oral Patol Oral Cir Bucal. 2019 May 1;24(3):e281-e289
pubmed: 31011137
Ethiop J Health Sci. 2014 Jul;24(3):235-42
pubmed: 25183930
J Prosthodont Res. 2016 Apr;60(2):85-91
pubmed: 26795728
Eur Arch Paediatr Dent. 2010 Oct;11(5):247-52
pubmed: 20932400
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
J Clin Oncol. 1999 Mar;17(3):1008-19
pubmed: 10071296
Community Dent Oral Epidemiol. 1997 Aug;25(4):284-90
pubmed: 9332805
Lancet. 2008 May 17;371(9625):1695-709
pubmed: 18486742
BMC Oral Health. 2014 Aug 04;14:95
pubmed: 25091189
Vojnosanit Pregl. 2009 Jul;66(7):511-5
pubmed: 19678573
J Oral Rehabil. 2012 Jan;39(1):18-27
pubmed: 21827525
Res Social Adm Pharm. 2008 Jun;4(2):83-97
pubmed: 18555963
Community Dent Health. 2004 Dec;21(4):306-11
pubmed: 15617416
Cad Saude Publica. 2013 Apr;29(4):749-57
pubmed: 23568304
Mayo Clin Proc. 2016 Mar;91(3):386-96
pubmed: 26944243
Health Qual Life Outcomes. 2015 Jan 23;13:9
pubmed: 25613348
Iran J Public Health. 2010;39(4):135-9
pubmed: 23113047
PLoS One. 2018 Jun 14;13(6):e0198840
pubmed: 29902243
J Dent Res. 2014 Jul;93(7):645-50
pubmed: 24782438
CA Cancer J Clin. 2012 Nov-Dec;62(6):400-22
pubmed: 22972543
G Ital Med Lav Ergon. 2010 Jul-Sep;32(3 Suppl B):B71-8
pubmed: 21302527
Indian J Cancer. 2017 Jan-Mar;54(1):11-15
pubmed: 29199653
J Consult Clin Psychol. 2013 Apr;81(2):299-317
pubmed: 22963591
Community Dent Health. 1994 Mar;11(1):3-11
pubmed: 8193981
J Int Oral Health. 2015 Aug;7(8):21-7
pubmed: 26464534
Value Health. 2003 Sep-Oct;6(5):522-31
pubmed: 14627058
Acta Odontol Latinoam. 2017 Aug;30(2):62-67
pubmed: 29248940